BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 9313873)

  • 1. Comparison of chemical characteristics of the first and the second cysteine-rich domains of protein kinase C gamma.
    Irie K; Yanai Y; Oie K; Ishizawa J; Nakagawa Y; Ohigashi H; Wender PA; Kikkawa U
    Bioorg Med Chem; 1997 Aug; 5(8):1725-37. PubMed ID: 9313873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The regulatory region of protein kinase C gamma. Studies of phorbol ester binding to individual and combined functional segments expressed as glutathione S-transferase fusion proteins indicate a complex mechanism of regulation by phospholipids, phorbol esters, and divalent cations.
    Quest AF; Bell RM
    J Biol Chem; 1994 Aug; 269(31):20000-12. PubMed ID: 8051084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A phorbol ester binding domain of protein kinase C gamma. High affinity binding to a glutathione-S-transferase/Cys2 fusion protein.
    Quest AF; Bardes ES; Bell RM
    J Biol Chem; 1994 Jan; 269(4):2953-60. PubMed ID: 8300627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Residues in the second cysteine-rich region of protein kinase C delta relevant to phorbol ester binding as revealed by site-directed mutagenesis.
    Kazanietz MG; Wang S; Milne GW; Lewin NE; Liu HL; Blumberg PM
    J Biol Chem; 1995 Sep; 270(37):21852-9. PubMed ID: 7665608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein kinase C contains two phorbol ester binding domains.
    Burns DJ; Bell RM
    J Biol Chem; 1991 Sep; 266(27):18330-8. PubMed ID: 1917958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the cysteine-rich region of the Caenorhabditis elegans protein Unc-13 as a high affinity phorbol ester receptor. Analysis of ligand-binding interactions, lipid cofactor requirements, and inhibitor sensitivity.
    Kazanietz MG; Lewin NE; Bruns JD; Blumberg PM
    J Biol Chem; 1995 May; 270(18):10777-83. PubMed ID: 7537738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solid-phase synthesis, mass spectrometric analysis of the zinc-folding, and phorbol ester-binding studies of the 116-mer peptide containing the tandem cysteine-rich C1 domains of protein kinase C gamma.
    Fukuda H; Irie K; Nakahara A; Ohigashi H; Wender PA
    Bioorg Med Chem; 1999 Jun; 7(6):1213-21. PubMed ID: 10428394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of ligand and substrate specificity for the calcium-dependent and calcium-independent protein kinase C isozymes.
    Kazanietz MG; Areces LB; Bahador A; Mischak H; Goodnight J; Mushinski JF; Blumberg PM
    Mol Pharmacol; 1993 Aug; 44(2):298-307. PubMed ID: 8355667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of phorbol ester binding to protein kinase C isotypes.
    Dimitrijević SM; Ryves WJ; Parker PJ; Evans FJ
    Mol Pharmacol; 1995 Aug; 48(2):259-67. PubMed ID: 7651359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cysteine-rich domain of human proteins, neuronal chimaerin, protein kinase C and diacylglycerol kinase binds zinc. Evidence for the involvement of a zinc-dependent structure in phorbol ester binding.
    Ahmed S; Kozma R; Lee J; Monfries C; Harden N; Lim L
    Biochem J; 1991 Nov; 280 ( Pt 1)(Pt 1):233-41. PubMed ID: 1660266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A phorbol ester binding domain of protein kinase C gamma. Deletion analysis of the Cys2 domain defines a minimal 43-amino acid peptide.
    Quest AF; Bardes ES; Bell RM
    J Biol Chem; 1994 Jan; 269(4):2961-70. PubMed ID: 8300628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The differential effects of protein kinase C activators and inhibitors on rat anterior pituitary hormone release.
    Thomson FJ; Johnson MS; Mitchell R; Wolbers WB; Ison AJ; MacEwan DJ
    Mol Cell Endocrinol; 1993 Aug; 94(2):223-34. PubMed ID: 8224525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phorbol ester and diacylglycerol activation of native protein kinase C species from various tissues.
    Johnson MS; Simpson J; MacEwan DJ; Ison A; Clegg RA; Connor K; Mitchell R
    Mol Cell Biochem; 1995 May; 146(2):127-37. PubMed ID: 7565642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular modeling and site-directed mutagenesis studies of a phorbol ester-binding site in protein kinase C.
    Wang S; Kazanietz MG; Blumberg PM; Marquez VE; Milne GW
    J Med Chem; 1996 Jun; 39(13):2541-53. PubMed ID: 8691452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence that protein kinase C alpha has reduced affinity towards 1,2-dioctanoyl-sn-glycerol: the effects of lipid activators on phorbol ester binding and kinase activity.
    MacEwan DJ; Mitchell R; Johnson MS; Thomson FJ; Lutz EM; Clegg RA; Connor K
    Eur J Pharmacol; 1993 Jun; 246(1):9-18. PubMed ID: 8354345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The solution structure of the Raf-1 cysteine-rich domain: a novel ras and phospholipid binding site.
    Mott HR; Carpenter JW; Zhong S; Ghosh S; Bell RM; Campbell SL
    Proc Natl Acad Sci U S A; 1996 Aug; 93(16):8312-7. PubMed ID: 8710867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Staurosporine up-regulates the expression of phorbol dibutyrate binding sites in human platelets.
    Rais S; Combadiere C; Hakim J; Perianin A
    Biochem Pharmacol; 1994 May; 47(10):1797-804. PubMed ID: 8204096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and properties of two distinct classes of the phorbol ester receptor family, four conventional protein kinase C types, and a novel protein kinase C.
    Akita Y; Ohno S; Konno Y; Yano A; Suzuki K
    J Biol Chem; 1990 Jan; 265(1):354-62. PubMed ID: 2294108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and phorbol ester-induced down-regulation of protein kinase C isozymes in osteoblasts.
    Sanders JL; Stern PH
    J Bone Miner Res; 1996 Dec; 11(12):1862-72. PubMed ID: 8970887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effector-dependent conformational changes in protein kinase C gamma through epitope mapping with inhibitory monoclonal antibodies.
    Cazaubon S; Webster C; Camoin L; Strosberg AD; Parker P
    Eur J Biochem; 1990 Dec; 194(3):799-804. PubMed ID: 1702715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.